HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Coxsackie virus hepatitis — Clinical Guidelines

Overview

Coxsackie virus hepatitis, primarily caused by enteroviruses within the Coxsackievirus genus, leads to liver inflammation. This condition is less commonly discussed compared to hepatitis caused by HBV or HCV but can present significant clinical challenges, particularly in specific populations 5.

Diagnosis

Clinical presentation includes nonspecific symptoms such as fever, fatigue, and jaundice.

Laboratory tests: Elevated liver enzymes (ALT, AST) and serology for Coxsackievirus antibodies may aid in diagnosis 5.

Imaging and biopsy: Rarely required but can help rule out other causes of liver disease 5.

Management

Supportive care: Focus on symptom management and hydration.

Antiviral therapy: Not typically indicated for Coxsackie virus hepatitis; treatment is generally supportive 5.

Monitoring: Regular follow-up to assess liver function and overall recovery 5.

Special Populations

Pregnancy: Limited specific guidance; general supportive care and monitoring are advised 5.

Pediatrics: Children may present with more severe symptoms; close monitoring and supportive care are crucial 5.

Elderly: Increased risk of complications; vigilant monitoring and supportive measures are necessary 5.

Comorbidities: Patients with pre-existing liver conditions may require more intensive monitoring and management 5.

Key Recommendations

Adhere to standard infection control precautions to prevent transmission in healthcare settings (Evidence: Expert opinion) 2 3.

Routine vaccination against hepatitis B is recommended for all obstetrician-gynecologists and other healthcare providers to prevent co-infections and complications (Evidence: Expert opinion) 2 3.

Monitor liver function closely in special populations, including pregnant women, children, and elderly patients, due to increased risk of complications (Evidence: Expert opinion) 5.

References

1 Lee SY, Shin HD. Meta-Analysis of Genetic Variants Associated With HBV Infection Susceptibility and Hepatocellular Carcinoma Risk. Journal of viral hepatitis 2026. link 2 . Committee Opinion No. 655: Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infections in Obstetrician-Gynecologists. Obstetrics and gynecology 2016. link 3 . Committee Opinion No. 655 Summary: Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infections in Obstetrician-Gynecologists. Obstetrics and gynecology 2016. link 4 Gomez EV, Rodriguez YS, Bertot LC, Gonzalez AT, Perez YM, Soler EA et al.. The natural history of compensated HCV-related cirrhosis: a prospective long-term study. Journal of hepatology 2013. link 5 Ogarkov PI, Malyshev VV, Tokmakov VS, Smirnov AV. Epidemiological features of virus hepatitis in the Russian Army. Minerva gastroenterologica e dietologica 2004. link 6 Sherlock S. Virus hepatitis B, A, non-A, non-B. Journal of hepatology 1989. link90016-0)

Coxsackie virus hepatitis